Dali Pharmaceuticalco.,Ltd reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 36.89 million compared to CNY 39.82 million a year ago. Revenue was CNY 36.89 million compared to CNY 39.82 million a year ago.

Net loss was CNY 2.55 million compared to CNY 3.21 million a year ago. Basic loss per share from continuing operations was CNY 0.0116 compared to CNY 0.0146 a year ago. Diluted loss per share from continuing operations was CNY 0.0116 compared to CNY 0.0146 a year ago.